2023
DOI: 10.1016/j.ijregi.2023.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Impact of COVID-19 on hepatitis B screening in Sierra Leone: insights from a community pharmacy model of care

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…Four studies reported relevant hepatitis B outcomes. 29 , 32 , 36 , 37 In a study from England, 88 people attending pharmacies for OAT or Needle Syringe Program (NSP) services or by self-referral with risk factors were tested with DBS tests. 29 Of these, one (1.1%) participant tested positive for hepatitis B surface antigen and subsequently had spontaneous clearance.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Four studies reported relevant hepatitis B outcomes. 29 , 32 , 36 , 37 In a study from England, 88 people attending pharmacies for OAT or Needle Syringe Program (NSP) services or by self-referral with risk factors were tested with DBS tests. 29 Of these, one (1.1%) participant tested positive for hepatitis B surface antigen and subsequently had spontaneous clearance.…”
Section: Resultsmentioning
confidence: 99%
“… 32 In a study from Sierra Leone, 920 people were tested, of which 161 (17.5%) were positive for hepatitis B surface antigen. 36 The authors of the three comparative studies using DBS testing were contacted for further information and advised only one positive hepatitis B case was detected from the total 660 tests conducted. 25 , 26 , 27 …”
Section: Resultsmentioning
confidence: 99%